| 000 | 01655 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516132949.0 | ||
| 264 | 0 | _c20130712 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1205-7541 | ||
| 024 | 7 |
_a10.1139/cjpp-2012-0215 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaini-Chohan, Harjot K | |
| 245 | 0 | 0 |
_aModification of Ca(2+)-handling in cardiomyocytes by redox sensitive mechanisms in response to ouabain. _h[electronic resource] |
| 260 |
_bCanadian journal of physiology and pharmacology _cJan 2013 |
||
| 300 |
_a45-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aOuabain _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 700 | 1 | _aHryshko, Larry | |
| 700 | 1 | _aXu, Yan-Jun | |
| 700 | 1 | _aDhalla, Naranjan S | |
| 773 | 0 |
_tCanadian journal of physiology and pharmacology _gvol. 91 _gno. 1 _gp. 45-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1139/cjpp-2012-0215 _zAvailable from publisher's website |
| 999 |
_c22464833 _d22464833 |
||